Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a prospective evaluation to determine the effectiveness of the Prostate Cancer Supportive Care (PCSC) Program's group therapy program, Living with Prostate Cancer (LPC). LPC is an intervention which utilizes a small group format (5-7 participants with 2 leaders and a paraprofessional counselling student) to understand and learn how to manage emotional responses, depressive symptoms, and life stressors associated with prostate cancer. Data for this evaluation will be derived from a focus group (at 3 months) and self-report questionnaires that participants will complete immediately prior to the intervention, immediately following the intervention and at 3, 6, and 12-months post-intervention.
The Vancouver Prostate Centre's (VPCs) PCSC Program is designed to address the gap in supportive care for men with prostate cancer (PC), their partners and their families. The evaluation protocol described here is specific to the program called "Living with Prostate Cancer" (LPC) from the Psychooncology module of the PCSC Program. The specific rationale for this module is that many cancer patients will experience significant anxiety or depression at some point along their cancer journey. The module includes private, confidential clinic appointments for PC patients and their spouses/partners, either separately or together, with our registered clinical counsellor, to explore how to cope with difficult emotions such as fear, anxiety, sadness, helplessness, and other signs of emotional distress. The module is now being expanded to include small group discussions. LPC is a group therapy program in which men participate in a guided autobiographical life review through a process that focuses on developing a cohesive working group, learning strategic communication skills, and understanding and learning how to manage difficult emotions and transitional life stressors associated with PC. It also focuses on the processing and integrating of critical events that contribute to the men's present day identity and psychological function and involves the consolidation of the personal learning that occurs. It shifts the focus on transitioning into the future by developing specific individual, family and/or career goals that are reinforced by ongoing support from peers in the group. Finally, post-group referral plans are developed on an individual basis as needed.
The group therapy program includes men with a diagnosis of PC Stages 1 to 3. We will administer validated quantitative tools to assess depression and anxiety, general psychological functioning, and male role norms (masculinity) before, after, and at 3, 6, and 12-months following the program. The meeting 3 months after the program will include a focus group process.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Changes in depressive and anxiety symptoms | Measured by the Beck Depression Inventory | Baseline (pre-workshop), 3-Weeks (Post-workshop), 3-, 6- and 12 Months |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in overall well-being | Measured by the Warwick-Edinburgh Mental Wellbeing Scale | Baseline (pre-workshop), 3-Weeks (Post-workshop), 3-, 6- and 12 Months |
| Changes in perceptions of masculinity |
Not provided
Inclusion Criteria:
Men are eligible to participate in this evaluation if they:
are older than 18 years old
are willing to attend the "Living with Prostate Cancer" group therapy sessions from the PCSC Program*
are able to speak and read English such that they are able to understand the questionnaires
have unimpaired cognitive function with an ability to understand the nature of the study
are willing to complete questionnaires at 5 time points
provide written informed consent
Exclusion Criteria:
Men will be ineligible to participate in this evaluation if they:
Not provided
Not provided
Not provided
The LPC Workshops will only include men with a diagnosis of Prostate Cancer Stages 1 to 3.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| David Kuhl, MD | University of British Columbia | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Vancouver Prostate Centre | Vancouver | British Columbia | V5Z 1M9 | Canada |
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Apr 20, 2023 | |
| Reset | Jan 19, 2024 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Apr 20, 2023 | Jan 19, 2024 |
| ID | Term |
|---|---|
| D011471 | Prostatic Neoplasms |
| ID | Term |
|---|---|
| D005834 | Genital Neoplasms, Male |
| D014565 | Urogenital Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Measured by the Personal Attributes Questionnaire
| Baseline (pre-workshop), 3-Weeks (Post-workshop), 3-, 6- and 12 Months |
| Changes in perceptions of masculinity | Measured by the Masculine Behaviour Scale | Baseline (pre-workshop), 3-Weeks (Post-workshop), 3-, 6- and 12 Months |
| Group cohesion and dynamics | Measured by the Group Questionnaire | 3-Weeks (Post-workshop), 3-, 6- and 12 Months |
| Patient-incurred costs for attending the session | Measured by an annotated cost questionnaire for completion by patients | 3-Weeks (Post-Workshop) |
| D005832 |
| Genital Diseases, Male |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D011469 | Prostatic Diseases |
| D052801 | Male Urogenital Diseases |